JP2012528186A5 - - Google Patents

Download PDF

Info

Publication number
JP2012528186A5
JP2012528186A5 JP2012513241A JP2012513241A JP2012528186A5 JP 2012528186 A5 JP2012528186 A5 JP 2012528186A5 JP 2012513241 A JP2012513241 A JP 2012513241A JP 2012513241 A JP2012513241 A JP 2012513241A JP 2012528186 A5 JP2012528186 A5 JP 2012528186A5
Authority
JP
Japan
Prior art keywords
compound
hydrogen
cancer
methyl
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012513241A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012528186A (ja
JP5686796B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/036312 external-priority patent/WO2010138665A1/en
Publication of JP2012528186A publication Critical patent/JP2012528186A/ja
Publication of JP2012528186A5 publication Critical patent/JP2012528186A5/ja
Application granted granted Critical
Publication of JP5686796B2 publication Critical patent/JP5686796B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012513241A 2009-05-28 2010-05-27 c−Metタンパク質キナーゼのアミノピラゾールトリアゾロチアジアゾール阻害剤 Expired - Fee Related JP5686796B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18178609P 2009-05-28 2009-05-28
US61/181,786 2009-05-28
PCT/US2010/036312 WO2010138665A1 (en) 2009-05-28 2010-05-27 Aminopyrazole triazolothiadiazole inhibitors of c-met protien kinase

Publications (3)

Publication Number Publication Date
JP2012528186A JP2012528186A (ja) 2012-11-12
JP2012528186A5 true JP2012528186A5 (OSRAM) 2013-06-20
JP5686796B2 JP5686796B2 (ja) 2015-03-18

Family

ID=42346870

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012513241A Expired - Fee Related JP5686796B2 (ja) 2009-05-28 2010-05-27 c−Metタンパク質キナーゼのアミノピラゾールトリアゾロチアジアゾール阻害剤

Country Status (25)

Country Link
EP (1) EP2435443B1 (OSRAM)
JP (1) JP5686796B2 (OSRAM)
KR (1) KR20120030110A (OSRAM)
CN (1) CN102459283B (OSRAM)
AR (1) AR076617A1 (OSRAM)
AU (1) AU2010254055B2 (OSRAM)
BR (1) BRPI1012037A2 (OSRAM)
CA (1) CA2762190A1 (OSRAM)
CL (1) CL2011002946A1 (OSRAM)
DK (1) DK2435443T3 (OSRAM)
ES (1) ES2433090T3 (OSRAM)
HR (1) HRP20130986T1 (OSRAM)
IL (1) IL216581A (OSRAM)
MX (1) MX2011012521A (OSRAM)
NZ (1) NZ596616A (OSRAM)
PL (1) PL2435443T3 (OSRAM)
PT (1) PT2435443E (OSRAM)
RS (1) RS53011B (OSRAM)
RU (1) RU2552993C2 (OSRAM)
SG (1) SG176574A1 (OSRAM)
SI (1) SI2435443T1 (OSRAM)
TW (1) TWI491614B (OSRAM)
UA (1) UA106082C2 (OSRAM)
WO (1) WO2010138665A1 (OSRAM)
ZA (1) ZA201108655B (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011012522A (es) * 2009-05-28 2012-02-08 Vertex Pharma Inhibidores de pirazol sustituido de proteina cinasa c-met.
JP2013527195A (ja) * 2010-05-27 2013-06-27 バーテックス ファーマシューティカルズ インコーポレイテッド c−Metプロテインキナーゼのアミノピラゾールトリアゾロチアジアゾールインヒビター
TR201113223A2 (tr) * 2011-12-29 2012-06-21 Koçak Farma İlaç Ve Ki̇mya Sanayi̇ A. Ş. Pemetrekset disodyum hazırlanmasına yönelik tek basamaklı işlem.
KR101373912B1 (ko) 2012-03-26 2014-03-13 중앙대학교 산학협력단 Shp-2의 활성을 특이적으로 저해하는 조성물 및 이의 제조방법
CN106924260B (zh) * 2015-12-31 2018-05-25 北京浦润奥生物科技有限责任公司 化合物在制备用于治疗脑胶质瘤的药物中的用途
CN109897054B (zh) * 2017-12-08 2021-12-10 中国药科大学 三唑并噻二唑类c-Met激酶抑制剂的制备方法及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5994341A (en) 1993-07-19 1999-11-30 Angiogenesis Technologies, Inc. Anti-angiogenic Compositions and methods for the treatment of arthritis
US6099562A (en) 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
CN1863780A (zh) * 2002-08-14 2006-11-15 沃泰克斯药物股份有限公司 蛋白激酶抑制剂及其应用
US7122548B2 (en) * 2003-07-02 2006-10-17 Sugen, Inc. Triazolotriazine compounds and uses thereof
JO2629B1 (en) * 2004-08-19 2012-06-24 افينتيس فارما سوتيكالز انك Branched carboxylic acid amides containing thienobirol, carboxylic acid amides containing pyrolithiazole, and the like as kinase inhibitors casein epsilon
ZA200804681B (en) * 2005-11-30 2009-11-25 Vertex Pharma Inc Inhibitors of C-Met and uses thereof
JP5144532B2 (ja) * 2005-11-30 2013-02-13 バーテックス ファーマシューティカルズ インコーポレイテッド c−Met阻害剤及び用法
NL2000613C2 (nl) * 2006-05-11 2007-11-20 Pfizer Prod Inc Triazoolpyrazinederivaten.
WO2008144767A1 (en) * 2007-05-21 2008-11-27 Sgx Pharmaceuticals, Inc. Heterocyclic kinase modulators
BRPI0921509A2 (pt) * 2008-11-19 2016-03-08 Vertex Pharma inibidor triazolotiadiazol de proteína quinase c-met
MX2011012522A (es) * 2009-05-28 2012-02-08 Vertex Pharma Inhibidores de pirazol sustituido de proteina cinasa c-met.

Similar Documents

Publication Publication Date Title
JP2019537570A5 (OSRAM)
JP2012509279A5 (OSRAM)
JP2012528186A5 (OSRAM)
JP2009514870A5 (OSRAM)
JP2016534063A5 (OSRAM)
JP2013537203A5 (OSRAM)
JP2020514311A5 (OSRAM)
JP2009513662A5 (OSRAM)
JP2013507415A5 (OSRAM)
JP2015508103A5 (OSRAM)
JP2013542261A5 (OSRAM)
JP2012532112A5 (OSRAM)
JP2013535437A5 (OSRAM)
JP2012524056A5 (OSRAM)
JP2013508288A5 (OSRAM)
JP2016522835A5 (OSRAM)
JP2016513137A5 (OSRAM)
JP2013519645A5 (OSRAM)
JP2012528185A5 (OSRAM)
JP2017529389A5 (OSRAM)
JP2018537535A5 (OSRAM)
RU2011124894A (ru) Триазолотиадиазоловый ингибитор протеинкиназы с-мет
JP2015522589A5 (OSRAM)
JP2015503596A5 (OSRAM)
JP2014503593A5 (OSRAM)